478
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Effect of Kollidon VA®64 particle size and morphology as directly compressible excipient on tablet compression properties

ORCID Icon, , &
Pages 19-29 | Received 03 Mar 2017, Accepted 12 Aug 2017, Published online: 06 Sep 2017

References

  • Maschke A, Meyer-Bohm K, Kolter K. Dry binders used in direct compression. ExAct. 2008;20:2–5.
  • Jivraj M, Martini LG, Thomson CM. An overview of the different excipients useful for the direct compression of tablets. Pharm Sci Technol Today. 2000;3:58–63.
  • Bultmann JM. Multiple compaction of microcrystalline cellulose in a roller compactor. Eur J Pharm Biopharm. 2002;54:59–64.
  • Herting MG, Kleinebudde P. Roll compaction/dry granulation: effect of raw material particle size on granule and tablet properties. Int J Pharm. 2007;338:110–118.
  • Falzone AM, Peck GE, McCabe GP. Effects of changes in roller compactor parameters on granulations produced by compaction. Drug Dev Ind Pharm. 1992;18:469–489.
  • Kleinebudde P. Roll compaction/dry granulation: pharmaceutical applications. Eur J Pharm Biopharm. 2004;58:317–326.
  • Malkowska S, Khan KA. Effect of re-compression on the properties of tablets prepared by dry granulation. Drug Dev Ind Pharm. 1983;9:331–347.
  • Nyström C, Karehill P. The importance of intermolecular bonding forces and the concept of bonding surface area. In: Alderborn G. Nyström C, eds. Pharmaceutical powder compaction technology. New York (NY): Marcel Dekker Inc; 1996. p. 17–53.
  • Zang Y, Law Y, Chakrabarti S. Physical properties and compact analysis of commonly used direct compression binders. AAPS PharmSciTech. 2003;4:489–499.
  • Kolter K, Flick D. Structure and dry binding activity of different polymers including Kollidon VA® 64. Drug Dev Ind Pharm. 2000;26:1159–1165.
  • Bolhuis G, Chowan Z. Material for direct compression. In: Alderborn G. Nyström C, editors. Pharmaceutical powder compaction technology. New York (NY): Marcel Dekker Inc; 1996. p. 419–500.
  • Parrott EL. Compression. In: Lieberman HA, Lachman L, Schwartz JB, editors. Pharmaceutical dosage forms: tablets. Vol. 2. New York (NY): Marcel Dekker Inc, 1990. p. 153–182.
  • Paronen P, Iilla J. Porosity–pressure functions. In: Alderborn G. Nyström C, editors. Pharmaceutical powder compaction technology. New York (NY): Marcel Dekker Inc; 1996. p. 55–75.
  • Bühler V. Kollidon – polyvinylpyrrolidone for the pharmaceutical industry. 9th ed. Ludwigshafen: BASF AG; 2008. p. 231–243.
  • Thoorens G, Krier F, Leclercq B, et al. Microcrystalline cellulose, a direct compression binder in a quality by design environment – A review. Int J Pharm. 2014;473:64–72.
  • Sheskey PJ, Dasbach TP, Tina P. Evaluation of various polymers as dry binders in the preparation of an immediate-release tablet formulation by roller compaction. Pharm Technol. 1995;19:98–112.
  • Bolhuis GK. Material for direct compaction. In: Alderborn G, Nytrom C, editors. Pharmaceutical powder compaction technology. New York (NY): Marcel Dekker Inc; 1996. p. 419–478.
  • Henriques J, Valente P, Winter C. Formulating amorphous solid dispersion: bridging particle engineering and formulation. Am Pharm Rev. 2016;19:26–30.
  • Jordan RP, Rhodes CT. Recording powder flow meters and their use in pharmaceutical technology. Drug Dev Ind Pharm. 1979;5:151–167.
  • de Jong JAH, Hoffmann AC, Finkers HJ. Properly determine powder flowability to maximize plant output. Chem Eng Progress. 1999;95:25–34.
  • Ashton MD, Cheng DCH, Farley R, et al. Some investigations into the strength and flow properties of powders. Rheol Acta. 1965;4:206–218.
  • Geldart D, Harnby N, Wong AC. Fluidization of cohesive powders. Powder Technol. 1984;37:25–37.
  • Harnby N, Hawkins AE, Vandame D. The use of bulk density determination as a means of typifying the flow characteristics of loosely compacted powders under conditions of variable relative humidity. Chem Eng Sci. 1987;42:879–888.
  • White HE, Walton SF. Particle packing and particle shape. J Am Ceram Soc. 1937;20:115–166.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.